| Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization. R Arranz, P Garcia-Alfonso, P Sobrino, P Zamora, R Carrion, ... Journal of clinical oncology 16 (4), 1538-1546, 1998 | 91 | 1998 |
| Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients JL Piñana, P Montesinos, R Martino, L Vazquez, M Rovira, J López, ... Annals of hematology 93, 299-307, 2014 | 64 | 2014 |
| Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: results of three prospective parallel trials … JM Ribera, O García, A Oriol, C Gil, P Montesinos, T Bernal, ... Leukemia research 41, 12-20, 2016 | 53 | 2016 |
| Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells L Suárez, MB Vidriales, MJ Moreno, A López, J García-Laraña, ... Haematologica 90 (1), 54-59, 2005 | 52 | 2005 |
| Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: a bridge to individualized medicine TA Bennett, P Montesinos, F Moscardo, D Martinez-Cuadron, J Martinez, ... Clinical Lymphoma Myeloma and Leukemia 14 (4), 305-318, 2014 | 48 | 2014 |
| CD34+ Cells from Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Normal Bone Marrow Display Different Apoptosis and Drug Resistance–Associated … L Suárez, MB Vidriales, J García-Laraña, G Sanz, MJ Moreno, A López, ... Clinical cancer research 10 (22), 7599-7606, 2004 | 44 | 2004 |
| Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia L Suárez, B Vidriales, J García-Laraña, A López, R Martínez, ... Haematologica 86 (12), 1287-1295, 2001 | 39* | 2001 |
| Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in … JL Steegmann, J Odriozola, F Rodriguez-Salvanés, P Giraldo, ... Haematologica 84 (11), 978-987, 1999 | 36 | 1999 |
| Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura CP Izquierdo, ME Mingot-Castellano, AEK Fuentes, ... Blood advances 6 (24), 6219-6227, 2022 | 32 | 2022 |
| Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in … R Sanchez, R Ayala, RA Alonso, MP Martínez, J Ribera, O García, ... Annals of hematology 96, 1069-1075, 2017 | 23 | 2017 |
| Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia C Motlló, JM Ribera, M Morgades, I Granada, P Montesinos, S Mercadal, ... Leukemia & Lymphoma 59 (1), 146-154, 2018 | 21 | 2018 |
| Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective … JM Ribera, O García, P Fernández-Abellán, E Lavilla, MT Bernal, ... British journal of haematology 159 (4), 2012 | 21 | 2012 |
| A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients D Martínez-Cuadrón, C Gil, J Serrano, G Rodríguez, J Pérez-Oteyza, ... Leukemia Research 76, 1-10, 2019 | 20 | 2019 |
| Simultaneous development of SLE-like syndrome and autoimmune thyroiditis following alpha-interferon treatment C Garcia-Porrua, MA González-Gay, F Fernandez-Lamelo, ... Clinical and experimental rheumatology 16 (1), 107-108, 1998 | 20 | 1998 |
| Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial C Simoes, B Paiva, D Martínez-Cuadrón, JM Bergua, S Vives, L Algarra, ... Blood Advances 5 (3), 760-770, 2021 | 19 | 2021 |
| Hypertriglyceridemia may be severe in CML patients treated with interferon‐α MJ Peñarrubia, JL Steegmann, E Lavilla, F Casado, MJ Requena, M Picó, ... American journal of hematology 49 (3), 240-241, 1995 | 19 | 1995 |
| Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia included in the ALL Ph08 … JM Ribera, O García, MJ Moreno, P Barba, I García‐Cadenas, S Mercadal, ... Cancer 125 (16), 2810-2817, 2019 | 18 | 2019 |
| A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia S Vives, D Martínez‐Cuadrón, J Bergua Burgues, L Algarra, M Tormo, ... Cancer 127 (12), 2003-2014, 2021 | 17 | 2021 |
| Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry A Villegas, R Núñez, A Gaya, MV Cuevas-Ruiz, JM Bosch, A Carral, ... Annals of Hematology 96, 1727-1733, 2017 | 16 | 2017 |
| A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses MJ Penarrubia, J Odriozola, C Gonzalez, I Massague, A Miguel, ... Annals of hematology 82, 750-758, 2003 | 14 | 2003 |
